Combining niacin, or vitamin B3, with chemotherapy, helped slow the progression and increase life span in mouse models of glioblastoma.
Researchers have discovered a way in which to sensitize drug-resistant human glioblastoma cells to chemotherapy.
A new STING treatment induces immunological responses that allow the immune system to fight otherwise immunological resistant glioblastoma cancer cells, researchers report.
A new study discovers molecular pathways that could lead to new targeted therapies which may potentially treat Glioblastoma, the most common and lethal form of brain cancer in adults.
By altering DON, an anti-cancer drug cultivated from bacteria originally found in Peruvian soil over 70 years ago, scientists believe they have made a safer and more tolerable form of the drug.
Researchers report a clinical trial of a personalized vaccine that targets glioblastoma brain cancer has successfully improved survival rates for patients.
Using a new algorithm, researchers find the loss of the KLHL9 gene is a driving force behind glioblastoma brain cancer.
Researchers have uncovered a new genetic cause of brain cancers and leukemia.
Researchers uncover a possible reason as to why astrocytomas don't respond to standard forms of cancer treatment.
Combining αGITR antibodies with ICBs resulted in stronger survival benefits in mouse models of human glioblastoma brain cancer.
Researchers delve deeply into the genomics of 599 GBM brain cancer cases to better target the disease.
Researchers suggest neural stem cells could be resistant to radiation. The stem cells could be roused from a hibernation-like state in order to reproduce and generate new cells which have the ability to migrate, replace injured cells and restore lost function.
